Institute of Pathology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome (2024) Schrezenmeier E, Choi M, Globke B, Dörner T, Leimbach A, Osmanodja B, Schramm A, et al. Journal article Artificial intelligence in kidney transplant pathology Künstliche Intelligenz in der Nierentransplantationspathologie (2024) Bülow RD, Lan YC, Amann KU, Boor P Journal article Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers. (2024) Rupprecht H, Catanese L, Amann KU, Hengel FE, Huber TB, Latosinska A, Lindenmeyer MT, et al. Journal article, Review article Potential and Uncertainties of RejectClass in Acute Kidney Graft Dysfunction: An Independent Validation Study. (2024) Von Samson-Himmelstjerna FA, Kakavand N, Gleske C, Schraml F, Basta AA, Braunisch MC, Bräsen JH, et al. Journal article Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing. (2024) Schlieben LD, Carta MG, Moskalev E, Stöhr R, Metzler M, Besendörfer M, Meidenbauer N, et al. Journal article Die Komplementkaskade in der Nierenpathologie (2024) Vonbrunn E, Daniel C Journal article Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial Cancer (2024) Klümper N, Eckstein M Journal article, Review article Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center (2024) Raptis D, Maak M, Krautz C, Merkel S, Brunner M, Agaimy A, Hartmann A, et al. Journal article Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer (2024) Klümper N, Vera-Badillo FE, Eckstein M, Hadaschik B, Grünwald V Journal article Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments (2024) Rüschoff J, Kumar G, Badve S, Jasani B, Krause E, Rioux-Leclercq N, Rojo F, et al. Journal article